Crossmark

Ultrasound guided stellate ganglion block as an adjunct to standard drug therapy in clinically diagnosed Alzheimer’s disease: an assessor blinded randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s40001-026-04360-6

Published Online: 2026-03-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ge, Yanan

Ding, Sheng

Dai, Shuangyong

Xie, Jiayi

Lang, Zegao

Zhang, Lixia

Zhang, Xiaochen
Funding

Funding for this research was provided by:

Taizhou Municipal Science and Technology Bureau (24ywb104)
License Information

Text and Data Mining valid from 2026-03-31

Accepted Manuscript valid from 2026-03-31
More Information

Article History

Received: 29 January 2026

Accepted: 26 March 2026

First Online: 31 March 2026

Declarations

:

: This study was approved by the Institutional Ethics Committee of the participating center (approval no. TZEY-KY-2024-003, 22 April 2024) and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants or their legal representatives before enrolment.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below